source
- Labcorp to acquire BioReference Health assets for $722M cashLabcorp and OPKO Health announced an agreement in which Labcorp will purchase select assets of BioReference Health, a subsidiary of OPKO. The assets include laboratory testing businesses focused o…
- China drafts policy to block foreign buyouts of key cell-gene therapy and siRNA platformsChina’s government has released a draft amendment to its export blacklist that would prohibit or tightly control foreign purchases of certain biopharmaceutical platforms. The rule targets propriet…